| Identification | Back Directory | [Name]
[7aS,(+)]-6,7,7a,8-Tetrahydro-7-methyl-5H-benzo[g]-1,3-benzodioxolo[6,5,4-de]quinoline | [CAS]
2030-53-7 | [Synonyms]
Aporeine
Aporheine
Aporrheine
d-Remerine
Isoremerine
d-Isoremerine
(+)-Aporrheine
(+)-Isoremerine
S-(+)-Roemerine
(7aS)-7-Methyl-6,7,7a,8-tetrahydro-5H-[1,3]benzodioxolo[6,5,4-de]benzo[g]quinoline
(6aS)-1,2-(Methylenebisoxy)-6-methyl-5,6,6aα,7-tetrahydro-4H-dibenzo[de,g]quinoline
[7aS,(+)]-6,7,7a,8-Tetrahydro-7-methyl-5H-benzo[g]-1,3-benzodioxolo[6,5,4-de]quinoline
5H-Benzo[g]-1,3-benzodioxolo[6,5,4-de]quinoline, 6,7,7a,8-tetrahydro-7-methyl-, (7aS,12aS)- | [Molecular Formula]
C18H17NO2 | [MDL Number]
MFCD23103599 | [MOL File]
2030-53-7.mol | [Molecular Weight]
279.33 |
| Chemical Properties | Back Directory | [Melting point ]
102° | [alpha ]
D22 +80° (c = 0.50 in ethanol) | [Boiling point ]
424.0±34.0 °C(Predicted) | [density ]
1.269±0.06 g/cm3(Predicted) | [pka]
6.1(at 25℃) |
| Hazard Information | Back Directory | [Uses]
Aporrheine can be used for topical delivery against skin cancer, and cardioprotective potential on doxorubicin induced cardiotoxicity in rats. It can also be used for alkaloid and terpenoid compounds isolated compounds to treat various infections. |
|
|